Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
Open Access
- 3 August 2015
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 47 (3) , 751-759
Abstract
The preclinical stage of frontotemporal lobar degeneration (FTLD) is not well characterized. We conducted a brain metabolism (FDG-PET) and structural (cortical thickness) study to detect early changes in asymptomatic GRN mutation carriers (aGRN+ ) thKeywords
This publication has 28 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadicsBrain, 2012
- Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degenerationBrain, 2011
- Suberoylanilide Hydroxamic Acid (Vorinostat) Up-regulates Progranulin TranscriptionJournal of Biological Chemistry, 2011
- Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndromeBrain, 2010
- Social cognition and the anterior temporal lobesNeuroImage, 2010
- Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's diseaseBrain, 2009
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other DementiasJournal of Nuclear Medicine, 2008
- Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic studyBrain, 2008
- Lesion analysis of the brain areas involved in language comprehensionCognition, 2004